|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RESEARCH |
A Gagnon, OHRI, Ottawa, Ontario, Canada
A Landry, OHRI, Ottawa, Ontario, Canada
A Sorisky, OHRI, Ottawa, Ontario, K1Y 4E9, Canada
Correspondence: Alexander Sorisky, Email: asorisky{at}ohri.ca
Abstract
To clarify how anti-adipogenic factors act on preadipocytes to inhibit their differentiation, we compared preadipocyte signaling responses generated by platelet-derived growth factor (PDGF; anti-adipogenic) versus insulin (pro-adipogenic). PDGF, but not insulin, stimulated the phosphorylation of inhibitor of kappa B kinase beta (IKK beta) in a time-dependent manner. This PDGF-dependent phosphorylation event was inhibited by 60% (P<0.05) when the cells were pretreated with wortmannin, indicating a requirement for the phosphatidylinositol (PI) 3-kinase /Akt pathway. IKK beta phosphorylation by PDGF was not accompanied by I kappa B alpha degradation nor NF-kappa B activation. PDGF inhibited human adipocyte differentiation, assessed by triacylglycerol accumulation (75% reduction; P<0.01), and by fatty acid synthase protein expression (60% reduction; P<0.05); these responses were no longer apparent in the presence of sc-514, a selective inhibitor of IKK beta. Our data describe a novel PDGF response in human preadipocytes that involves the pro-inflammatory kinase IKK beta and demonstrate that it is required for the inhibition of adipogenesis.
| HOME | HELP | CONTACT US | SUBSCRIPTIONS | ARCHIVE | SEARCH |